Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" tariffs targeting countries rather than products, while signaling a hawkish ...
Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's potential in the ...
Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...
Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...
Cantor Fitzgerald currently has a “Overweight” rating and a $9.00 target price on the stock. The consensus estimate for Prenetics Global’s current full-year earnings is ($3.30) per share ...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – Cantor Fitzgerald issued their FY2025 earnings estimates for Arcturus Therapeutics in a report released on Tuesday ...
The 20-foot wide mansion was built in 1869 along with three others on East 74th Street, and was significantly redesigned in ...
Cantor Fitzgerald assumed coverage of Cidara Therapeutics (CDTX) with an Overweight rating. Cidara’s lead asset CD388, an anti-viral that targets neuraminidase, an essential surface receptor ...
This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...
In preparation for the launch, Cantor Fitzgerald hosted a discussion with a Senior Director of Product Development at UnitedHealth (NYSE:UNH). The conversation provided insights into the coverage ...
On Wednesday, Cantor Fitzgerald adjusted its price outlook for Meta Platforms Inc. shares (NASDAQ: NASDAQ:META), setting the new target at $720, a slight decrease from the previous $730 ...
Hosted on MSN13d
Cantor Fitzgerald Initiates Coverage of Oracle (ORCL) with Overweight RecommendationFintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of Oracle (NYSE:ORCL) with a Overweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback